Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)

Department of Health and Human Services · National Institutes of Health · SBIR Topic · FOR-CA-25-086

posted 16 June 2025 · closed 30 October 2025

This solicitation's response window has closed.

Summary

The National Cancer Institute plans to issue a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards that will provide additional funding to small businesses advancing cancer‑relevant technologies toward commercialization. The effort aims to pair federally funded projects with third‑party investors to accelerate the capital‑intensive steps needed to bring new products and services to market, including preclinical or clinical development.

View the official notice ↗

Want to know why the government is buying what they buy? Subscribe to the OODA Daily Pulse

The OODA Daily Pulse Report provides a detailed summary of the top technology, cybersecurity and global risks of the day. Our analysts curate stories, articles and insights from hundreds of vetted sources to inform your decisions and our research team provides long form context on topics destined to be of importance. Delivered free to your inbox five days a week at 10:00am.